What is the Share Price of Dr Reddys Laboratories Ltd?

Dr Reddys Laboratories Ltd share price is ₹1,177.40 As on 02 May, 2025|09:24

Home
>
Stocks
>
Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd Share Price

Q: What is the Market Cap of Dr Reddys Laboratories Ltd?

The Market Cap of Dr Reddys Laboratories Ltd is ₹98,791 As on 02 May, 2025|09:24

Q: What is PE Ratio of Dr Reddys Laboratories Ltd?

The P/E ratio of Dr Reddys Laboratories Ltd is 18.4 As on 02 May, 2025|09:24

Q: What is PB Ratio of Dr Reddys Laboratories Ltd?

The PB ratio of Dr Reddys Laboratories Ltd is 3.19 As on 02 May, 2025|09:24

₹ 1,177.40 -6.50 (-0.55%)
Updated on 02-05-2025 9:24 AM

Stock Rating

Pros 2

Cons 4

Option Chain

Dr Reddys Laboratories Ltd Price Performance

Day's Low
₹1,174

Day's High
₹1,188

₹ 1,177.40

52-w low
₹1,020

52-w high
₹1,421.49

1,177.40

Day's open
₹1,176.10
Previous close
₹1,183.90
VWAP
₹1,180.42
Lower price band
₹1,065.60
Upper price band
₹1,302.20

Today's Market Action

The last traded share price of Dr Reddys Laboratories Ltd was 1,177.40 down by -0.55% on the NSE. Its last traded stock price on BSE was 1,177.25 down by -0.49%. The total volume of shares on NSE and BSE combined was 91,003 shares. Its total combined turnover was Rs 10.74 crores.

Dr Reddys Laboratories Ltd Medium and Long Term Market Action

Dr Reddys Laboratories Ltd hit a 52-week high of 1,421.49 on 21-08-2024 and a 52-week low of 1,020 on 07-04-2025. The stock price of Dr Reddys Laboratories Ltd is up by 3% over the last one month. Don't forget to check the full stock price history in the table below.

Dr Reddys Laboratories Ltd Fundamentals

Market Cap (Cr): 98791
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Dr Reddys Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Dr Reddys Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Dr Reddys Laboratories Ltd

Data not available.

Dr Reddys Laboratories Ltd FAQ's

What is Share Price of Dr Reddys Laboratories Ltd?

What is the Market Cap of Dr Reddys Laboratories Ltd?

What is PE Ratio of Dr Reddys Laboratories Ltd?

What is PB Ratio of Dr Reddys Laboratories Ltd?

What is the CAGR of Dr Reddys Laboratories Ltd?

How to Buy Dr Reddys Laboratories Ltd Share?

Can I buy Dr Reddys Laboratories Ltd from Samco?

How do I buy Dr Reddys Laboratories Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.

Cons

Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.57. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 191 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(02/05/2025)

101

Margin of Safety Index: High

0% People are bullish about Dr Reddys Laboratories Ltd

0 % People are bearish about Dr Reddys Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %